Home > Sciences De La Vie > Industrie Pharmaceutique > Thérapies > MarketWatch: CNS
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Thérapies > Etude de marché sectorielle
 MarketWatch: CNS
€ 160,00
Editeur :
Datamonitor
Langue :
Anglais
Date de publication :
Janvier 2005
Taille du document :
25
Autres informations :
Description , Table des matières
 
Recevez cette publication aujourd'hui !
Plus d'information ?
09 70 463 423
 
Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
MarketWatch: Cancer
33 pages | Mars 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the
160,00 €
 
 
Stakeholder Insight: Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
199 pages | Avril 2005 |
IntroductionAnthracycline-based regimens and tamoxifen are well-established in the treatment of early-stage breast cancer.
In recent days, however, agents such as Sanofi-Aventis's Taxotere and Astr
9 120,00 €
 
 
The Cancer Market Outlook to 2010
192 pages | Novembre 2005 |
The cancer market has undergone a high degree of innovation led change over the previous five years, which has created strong opportunities for a range of established and emerging biotechnology and ph
2 443,75 €
 
 
MarketWatch: Cancer
29 pages | Avril 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the
160,00 €
 
 
MarketWatch: Cancer
29 pages | Octobre 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the
170,00 €
 
 
Chinese Markets for Cancer Treatment Drugs
218 pages | Septembre 2002 |
China's demand for cancer treatment drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's e
2 835,00 €
 
 
MarketWatch: Cancer
32 pages | Juillet 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the
160,00 €
 
 
Commercial Insight: Antihormonal Therapies Aromatase Inhibitors Reinvigorate a Mature Market
122 pages | Juillet 2005 |
IntroductionThe antihormonal cancer therapy market is characterized by a mature nature and a relatively high level of saturation.
Despite this, growth will continue slowly at a CAGR of 0.9% during
12 160,00 €
 
 
MarketWatch: CNS
27 pages | Mai 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys
160,00 €
 
 
MarketWatch: Cancer
30 pages | Juin 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the
160,00 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 MarketWatch: CNS

Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the
 
CNS industry.


 

In this month’s MarketWatch…
 

 

 
This month's highlights
 
Page 2 - Key Announcements
 
Page 2 - CNS News Round-Up
 

 
Neurology
 
Page 4 - Opinion: Schwarz: lacosamide on track for dual approval…
 
Page 5 - Headlines
 
Page 5 - Alzheimer's Disease Update
 
Page 6 - Multiple Sclerosis Update
 
Page 7 - Parkinson's Disease Update
 

 
Psychiatry
 
Page 9 - Headlines
 
Page 9 - Depression Update
 
Page 11 - Behavioral Disorders Update
 

 
Pain
 
Page 13 - Headlines
 
Page 13 - R&D Update
 
Page 15 - Regulatory Update
 
Page 16 - Licensing & Collaborations Update
 

 
Company Spotlight
 
Page 18 - Forest Laboratories
 

 
Further Reading
 
Page 23
 

 

 
Index
 
Page 24 - Pharma companies
 
Page 24 - Biotech companies
 
Page 25 - Key Drugs
 


New Search:

PPLSEN